Moreover, as these molecules target the CFTR protein, they are ineffective for pwCF who have variants that do not produce any CFTR protein such as the premature termination codon (PTC) variants such as G542X and W1282X, the 2nd and 5th most common CF-causing variants respectively. Here, CFTR is linked to cystic fibrosis.